Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Dayan

Plastic Surgery Chicago, IL Medical Doctor

NPI 1326034786 CMS profile 14337

845 N Michigan Ave, 9Th Floor, Chicago, IL 60611

Open in the dashboard

General payments

$1,236,670

447 records reported · program years 2019–2025

Research payments

$2,209

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,935,916 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Steven Dayan of Chicago, IL is reported in the CMS Open Payments database as having received $1,236,670 across 447 general payments and $2,209 in research payments paid to them. Separately, studies naming them as principal investigator received $1,935,916 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $237,167 38
2024 General $204,435 51
2024 Research $1,051 3
2023 General $48,175 35
2022 General $65,818 38
2021 General $120,367 52
2020 General $223,729 45
2019 General $336,978 188
2019 Research $1,159 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Dayan
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Steven Dayan were reported at $237,167. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Steven Dayan Plastic Surgery median Middle half National median
2019 $336,978 $371 $122–$1,483 $163
2020 $223,729 $158 $52–$438 $114
2021 $120,367 $249 $87–$752 $132
2022 $65,818 $274 $102–$793 $149
2023 $48,175 $299 $113–$891 $160
2024 $204,435 $361 $124–$1,062 $164
2025 $237,167 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Galderma Laboratories, L.P. $588,238 124 payments
  2. Allergan Inc. $295,680 140 payments
  3. Merz North America, Inc. $179,849 96 payments
  4. AbbVie, Inc. $157,566 57 payments
  5. Arthrex, Inc. $10,511 4 payments
  6. Endo Pharmaceuticals Inc. $3,109 14 payments
  7. Botanix SB Inc $1,000 1 payment
  8. Revance Therapeutics, Inc. $540 6 payments
  9. Aclaris Therapeutics, Inc. $135 3 payments
  10. Solta Medical, a division of Bausch Health US, LLC $22 1 payment
  11. Other $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $834,221 125 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $177,248 27 payments
  3. Grant $140,098 12 payments
  4. Travel and Lodging $71,602 100 payments
  5. Food and Beverage $13,460 178 payments
  6. Education $41 5 payments
Products named General payments · program years 2019–2025
  1. Xeomin Dermatology $134,803 63 payments
  2. BOTOX COSMETIC $58,830 61 payments
  3. BOTOX $23,178 28 payments
  4. (Plus) $2,610 1 payment
  5. SOFDRA $1,000 1 payment
  6. Xeomin musculoskeletal $939 4 payments
  7. ASCLERA $590 4 payments
  8. DAXXIFY $540 6 payments
  9. DYSPORT $243 3 payments
  10. NATRELLE SALINE-FILLED BREAST IMPLANTS $147 3 payments
  11. Other $257 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Allergan Inc. $1,159 7 payments
  2. AbbVie, Inc. $1,051 3 payments

Records

457 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record